January 26, 2026 · Form 4 insider transaction
Huntsman Carole sold 570 shares of Madrigal Pharmaceuticals, Inc. at $494.59 per share, a transaction worth $281.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024.